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Implications for Nursing Care 
Acute Respiratory Distress Syndrome 
Rachael B. Gale, RN, BSN, CCRN 
Signs and Symptoms 
Pathophysiological Process References 
Significance of Pathophysiology 
•  Acute alveolar injury results in 
release of inflammatory cytokines 
(tumor necrosis factor, IL-1, IL-6, 
IL-8) that enlist neutrophils to 
become active in the lungs and 
inflict damage to the capillary 
endothelium and alveolar 
epithelium through discharge of 
toxins (Butt et al., 2016). 
•  The damaged capillary membrane 
leaks protein from the vascular 
space and disrupts the oncotic 
gradient that normally regulates 
absorption of fluid, allowing fluid 
to leak into the interstitial space 
(Butt et al., 2016).  
•  The interstitial lymphatic system, 
which normally returns fluid to the 
vascular system, is unable to 
displace the large volume of fluid 
and becomes inefficient (Butt et 
al., 2016). 
•  The airway spaces become flooded 
with excess fluid made up of 
proteins and waste products that 
are results of cell injury (Albert, 
2012). 
•  Surface tension is lost due to 
decreased amount of surfactant 
that leads to collapse of the alveoli 
(Albert, 2012). 	  	  
•  Typically occur within 6 to 72 
hours of initial lung injury, most 
often caused by sepsis, 
pneumonia, aspiration, trauma 
and blood administration (Laffey, 
Pham, & Bellani, 2017). 
•  Often present with shortness of 
breath, respiratory distress, diffuse 
crackles, tachypnea, tachycardia 
and hypoxemia (Gong et al., 2016). 
•  Arterial blood gas measurement 
features hypoxemia and 
respiratory acidosis, even on high 
levels of delivered fraction of 
inspired oxygen (fi02) 
(Modrykamien & Gupta, 2015).  
•  Chest radiograph may show 
alveolar infiltrates or edema, 
decreased aeration and diffuse 
airspace opacities (Laffey et al., 
2017). 
•  In mechanical ventilation, plateau 
pressures exceed 30 cm H20 
(Gong et al., 2016). 	  
•  Impaired gas exchange results in 
refractory hypoxemia due to 
ventilation-perfusion mismatch 
and physiologic shunting 
(Albert, 2012). 
•  Increased physiologic dead 
space results in diminished 
ventilation, causing hypercarbia 
(Kallet, Zhuo, Liu, Caffee, & 
Matthay, 2014). 
•  Inflammatory changes lead to 
decreased lung compliance, 
causing high airway pressures 
and difficulty in ventilation 
(Gong, Thompson, Taylor, & 
Gong, 2016). 
•  Pulmonary hypertension may 
occur as a result of 
vasoconstriction secondary to 
hypoxia and physical 
compression due to high levels of 
positive airway pressure in 
mechanically ventilated patients 
(Viellard-Baron et al., 2016). 
•  In the final fibro-proliferative 
phases, scar tissue will form, 
leading to permanent pulmonary 
dysfunction  (Albert, 2012). 
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•  	  Minimize oxygen consumption by 
treating fever, pain and anxiety 
(Laffey et al., 2017). 
•  Sedation and neuromuscular 
blockade are often required to 
suppressive the patient’s intrinsic 
respiratory pattern and optimize 
mechanical ventilation (Gong, 
Thompson, Taylor, & Gong, 
2016). 
•  Judicious fluid administration 
decreases further fluid leakage 
through capillary beds (Viellard-
Baron et al., 2016). 
•  Hemodynamic monitoring allows 
for tightly controlled treatment of 
hemodynamic instability and 
intravascular volume status 
(Viellard-Baron et al., 2016).	  
•  Prone positioning, extracorporeal 
membrane oxygenation (ECMO) 
and high frequency oscillation 
ventilation (HFOV) may be 
considered in severe cases of 
refractory hypoxemia (Albert, 
2012). 
•  Low tidal volume ventilation 
(LTVV) aims to prevent 
alveolar overdistention and 
barotrauma (Mosier et al., 
2015). 
•  LTVV is achieved through 
calculating and delivering tidal 
volumes of 6 ml/kg using 
predicted body weight (Davies 
et al., 2015). 
•  Increased respiratory rate 
(maximum 35 breaths per 
minute) compensates to 
achieve adequate minute 
ventilation (Mosier et al., 2015). 
•  Goal plateau pressure is less 
than 30 cm H20 (Davies et al., 
2015). 
•  Fi02 and positive end 
expiratory pressure (PEEP)  
are increased in tandem 
(Mosier et al., 2015). 
•  Goal arterial oxygen tension 
(PaO2) is 55-80 mmHg and 
ideal oxygen saturation is 
between 88 and 95% (Mosier et 
al., 2015). 	  
Ventilator Management 
Introduction 
Why ARDS? 
•  Symptoms occur within seven 
days of initial lung injury (Laffey, 
Pham, & Bellani, 2017). 
•  Impaired oxygenation as 
evidenced by Pa02/Fi02 ratio of 
<200 mm Hg for moderate 
ARDS and <100 mm Hg for 
severe ARDS (Laffey et al., 
2017). 
•  Chest radiograph reveals 
presence of non-cardiogenic 
pulmonary edema as bilateral 
opacities (Laffey et al., 2017). 	  	  
•  Acute respiratory distress syndrome (ARDS) is a complex disease state with varied 
causality, multiple pathophysiologic mechanisms and numerous treatment 
modalities.   
•  Patients who develop ARDS are often extraordinarily ill and require prolonged 
stays in the intensive care unit with extensive medical intervention.  The 
development of identification and treatment of ARDS has a storied history and 
continues to evolve in clinical practice with little progress toward improved patient 
outcomes.   
•  “Mortality from ARDS has been estimated at 26-58%” in the United States (U.S.) 
despite decades of study and advances in therapy (Modrykamien & Gupta, 2015, p. 
163).   
•  Extensive research has been conducted regarding ventilation modalities and 
medical management with minimal improvement in rates of morbidity and 
mortality (Butt, Kurdowska, & Allen, 2016).   
•  As the overall health of the general population continues to decline as evidenced by 
rising obesity rates, an generally aging population and increased incidence of 
multiple medical comorbidities, treatment of the patient in ARDS becomes more 
challenging (Hibbert, Rice, & Malhotra, 2012).   
•  An advanced practitioner armed with a thorough understanding of the history, 
pathophysiology and evidenced-based treatment modalities is best equipped to 
care for patients with ARDS. 
•  ARDS is a syndrome that affects patients of many different 
populations and the tenets of disease management are concepts that 
are integral in the care provided as a Certified Registered Nurse 
Anesthetist (CRNA). 
•  ARDS affects approximately 86 of 100,000 patients and there are 
roughly 190,000 cases in the United States every year (Gong, 
Thompson, Taylor, & Gong, 2016). 
•  The pathophysiology of ARDS is complex and requires an in-depth 
understanding of several concepts including pulmonary, 
inflammatory, acid-base imbalances and distribution of body fluids. 
•  There has been a significant amount of research regarding the 
management of ARDS and in-depth knowledge of evidence-based 
practice guidelines is essential to the care of a CRNA 
Underlying Pathophysiology Diagnostic Criteria 
Adjunct Therapies and 
Supportive Care 
Conclusion 
•  ARDS is a complex disease 
state with varied 
pathophysiologic factors and 
multiple treatment modalities. 
•  Early recognition and 
aggressive management 
contribute to improved patient 
outcomes due to the 
syndrome’s high incidence and 
impact on critically ill patients. 
•  Lung protective ventilation is 
imperative and must be 
managed closely. 
•  Understanding of the 
diagnosis and treatment is an 
important quality for the 
advanced practice nurse caring 
for critically ill patients. 
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